Taxmann’s Securities and Exchange Board of India (SEBI) Act, 1992 (Bare Act) – Edition 2026.
Main Description / Overview
Undeniably, this bare act makes complex financial laws very clear. For instance, the text explains the strict rules of market manipulation easily.
Consequently, readers easily grasp the exact statutory modes of corporate compliance. Ultimately, it logically divides the act into clear regulatory sections.
Furthermore, it covers everything from insider trading to investor protection. Therefore, it acts as an essential daily reference tool for corporate lawyers.
Target Audience
Clearly, this book serves Indian law students and financial practitioners directly. Therefore, it gives direct help to these specific users.
First, it supports trial advocates drafting complex securities appeals.
Second, it helps law students preparing for university LLB exams.
Third, it guides corporate officers understanding strict market boundaries.
Key Features of the 2026 Edition
Significantly, Taxmann updated this essential bare act perfectly. As a result, it offers several highly useful tools for readers.
First, it integrates the fundamental statutory amendments perfectly.
Furthermore, it includes comprehensive bare text without confusing commentary.
Specifically, it provides clear section headings for quick reference.
Moreover, it explains the complex rules of regulatory penalties clearly.
Additionally, it uses simple formatting to highlight deep financial concepts.
Detailed Chapter Breakdown
Structurally, the book covers all major securities topics across detailed chapters. Initially, it maps the entire framework of capital markets perfectly.
First, it clearly explains the core principles of the SEBI establishment.
Next, it fully details the exact procedures for registering market intermediaries.
Furthermore, it perfectly outlines the strict regulations regarding fraudulent trade practices.
Moreover, it tackles the complex rights regarding appellate tribunals.
Finally, it details the strict statutory approaches towards corporate financial disclosures.



Reviews
There are no reviews yet.